SCHEMBL4158637

SCHEMBL4158637

O=C(CBr)OBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100137 0.74
SCHEMBL875655 0.74
SCHEMBL337863 0.74 TSHR (0.44)
SCHEMBL6501758 0.73
SCHEMBL6016299 0.71
SCHEMBL8442017 0.71 TRPA1 (0.63)
SCHEMBL3295212 0.69
SCHEMBL25435249 0.69
SCHEMBL1331006 0.69
SCHEMBL6485843 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659045-A Synthesis method of desacetoxy cefathiamidine 江苏汉斯通药业有限公司 2024-03-08 CN claimed
CN-117659045-A Synthesis method of desacetoxy cefathiamidine 江苏汉斯通药业有限公司 2024-03-08 CN disclosed
CN-103664973-B Spiro-oxindole compounds and their use as therapeutic agents 泽农医药公司 2017-04-19 CN disclosed
CN-105916499-A 12-epi-pleuromutilins 纳布里瓦治疗股份公司 2016-08-31 CN disclosed
US-20090068719-A1 IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS VALDEZ JOHNNY 2009-03-12 US disclosed
EP-1700122-A4 IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS ARK DIAGNOSTICS INC (US) 2008-05-21 EP disclosed
EP-1700122-A2 IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS ARK DIAGNOSTICS (US) 2006-09-13 EP disclosed
US-20050244816-A1 Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics ARK DIAGNOSTICS, INC. (US) 2005-11-03 US disclosed
WO-2005062979-A2 IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS ARK DIAGNOSTICS (US) 2005-07-14 WO disclosed